Patterns of Inheritance of Inborn Errors of Immunity in a Cohort of B-Cell Lymphoproliferative Disorders: an in Silico Approach

The human immune system is a vast, intricate network designed to distinguish friend from foe, protecting the body from infections while keeping its own cells in check. Sometimes, this system fails. In some people, the failure is born from a genetic mistake present from birth, known as an inborn error of immunity. These individuals often struggle with severe, recurring infections and are at a higher risk of developing blood cancers. In other cases, the immune system appears to break down later in life, a condition called secondary immunodeficiency, often triggered by diseases like lymphoma, a cancer of the white blood cells. For decades, doctors have treated these two scenarios as distinct: one a genetic condition starting at birth, the other a consequence of disease. However, a growing number of patients with lymphoma show signs of immune failure that look suspiciously like those born with genetic immune defects, raising a difficult question: are these two conditions actually separate, or do they share a hidden genetic root?

A team of researchers at Hospital Clínico San Carlos in Spain set out to investigate this mystery by looking directly at the genetic code of patients with B-cell lymphoproliferative disorders. These are cancers where a specific type of white blood cell, the B-cell, multiplies uncontrollably. The scientists focused on 78 patients who had been diagnosed with this type of cancer and also showed signs of secondary immune deficiency. Using a powerful technology called whole exome sequencing, which reads the parts of DNA that provide instructions for making proteins, the researchers searched for genetic variants linked to immune system failures. To ensure their findings were meaningful, they compared these results against a database of the general population and against a separate group of 56 patients who had already been diagnosed with primary immunodeficiencies, the classic genetic immune disorders.

The study revealed a striking connection. More than half of the cancer patients, specifically 55 percent, carried at least one genetic variant associated with immune system errors. This frequency was significantly higher than what is found in the general population, suggesting that these genetic mistakes are not just random background noise but are likely linked to the development of the cancer. The researchers found 62 different genetic variants across 35 different genes in these patients. While the overall rate of finding these genetic errors was similar to that of patients with primary immunodeficiencies, the nature of the errors told a different story. The patients with cancer were more likely to carry genetic changes in genes responsible for immune regulation and combined immune defects, whereas the primary immunodeficiency patients had more changes in genes related to antibody production.

Perhaps the most intriguing discovery was how these genetic errors appeared in the cancer patients. In the group with primary immunodeficiencies, the genetic mistakes often appeared as single, clearly harmful changes in genes that follow a dominant inheritance pattern, meaning one copy of the bad gene is enough to cause trouble. In contrast, the cancer patients showed a more complex picture. They frequently carried multiple genetic variants at the same time, a situation known as co-occurrence. They were also more likely to have variants in genes that usually require two copies to be defective to cause disease, known as recessive inheritance. This suggests that for these cancer patients, the path to illness might involve a combination of several smaller genetic hits rather than one single, overwhelming error.

To understand what these genetic changes meant for the body, the researchers used computer models to map how the proteins made by these genes interact with one another. The analysis showed that the genes affected in the cancer patients clustered into groups responsible for critical tasks: repairing DNA, regulating how immune cells die and multiply, and managing the body's response to inflammation. When these specific systems are impaired, even slightly, it can create an environment where cells are less able to fight off viruses and more prone to turning cancerous. The study also found that the genetic profiles of the cancer patients overlapped significantly with those of patients who suffer from recurrent infections, reinforcing the idea that the same biological pathways are involved in both immune failure and cancer development.

The findings suggest that the line between primary immunodeficiency and secondary immune deficiency caused by cancer is blurrier than previously thought. The researchers propose that some patients with lymphoma may actually have an underlying genetic predisposition that was undiagnosed until the cancer appeared. This does not mean that every case of lymphoma is caused by a genetic immune defect, but it does indicate that a substantial portion of these patients carry a genetic landscape that makes them vulnerable. The study concludes that the genetic errors found in these cancer patients are real, measurable, and distinct from the general population, offering a new perspective on why these diseases occur. By identifying these patterns, the research opens the door to a deeper understanding of how immune system failures and blood cancers are intertwined, potentially guiding future strategies for diagnosis and treatment that look beyond the cancer itself to the genetic foundation of the patient's immune health.